Wolverine Asset Management LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Wolverine Asset Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 04, 2024	SELL	$460.0 - $505.78 $1.79 Million - $1.97 Million	-3,900 Reduced 70.91%	1,600 $744,000
Q2 2024 Aug 01, 2024	BUY	$392.81 - $485.53 $1.02 Million - $1.26 Million	2,600 Added 89.66%	5,500 $2.58 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $1.18 Million - $1.29 Million	2,900 New	2,900 $1.21 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $6.86 Million - $7.78 Million	-50,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $7.41 Million - $8.11 Million	50,000	50,000 $7.6 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.